INTRODUCTION
Despite decades-long efforts to improve healthcare delivery systems worldwide, there remain deficiencies in the quality and safety of care patients receive. [1] [2] [3] [4] Hospitals are continuously assessed for levels of quality, safety and performance using a range of methods, bolstered by policies and regulatory activities at national, state or regional, local, and hospital levels. 5 Assessments can be resource-intensive, and are often conducted with invalidated tools, or in a piecemeal manner. 6 Results are typically used to demonstrate policy compliance, rather than to stimulate improvement.
Strengths and limitations of this study
▪ This is an in-depth study examining quality management systems and patient factors in a large sample of hospitals, substantially advancing earlier work. ▪ We consulted widely with Australian and international stakeholders in order to operationalise definitions and measures in acute myocardial infarction, stroke and hip fracture. ▪ The study informs the design of future interventions and quality management systems in Australia and internationally. ▪ Key challenges include sufficient sample sizes, the recruitment of hospitals (n=∼60), complex ethical, governance and site approval processes and attrition of recruited hospitals during the approval process.
Few studies in healthcare research systematically examine relationships between quality interventions and patient outcomes. 7 Despite the growing body of research, there is little evidence of the association between the way hospitals are organised for quality and patient outcomes, limiting our understanding of how to effect large-scale change. 8 9 In recognition of this, a large multinational study 'Deepening our Understanding of Quality Improvement in Europe' (DUQuE) was undertaken between 2009 and 2014. 10 This landmark study, undertaken in 188 hospitals across seven countries (Czech Republic, France, Germany, Poland, Portugal, Spain and Turkey), examined the effectiveness of quality management systems (QMS) and strategies at organisation, department, professional and patient levels for stroke, acute myocardial infarction (AMI), hip fracture and obstetrics. DUQuE aimed to improve the way quality strategies and their effects on performance and outcomes were measured in European hospitals [11] [12] [13] [14] by uncovering the relationships between them. This study also aimed to identify factors influencing the uptake of quality management activities by hospitals, and establish the feasibility of using routinely collected data to compare hospital performance. 10 DUQuE developed and validated several tools for European acute care hospitals, assessing the implementation of QMS, 15 compliance with quality processes and the extent of implementation of clinical quality strategies at hospital level, 16 departmental performance and the implementation of quality management activities across specific departments and care pathways, 17 and levels of clinical management provided by doctors and nurses. 18 Key published findings from DUQuE include:
▸ Low baseline performance and high variations were found on a wide range of evidence-based quality and safety indicators; levels of patient involvement in quality management were found to be low and appeared tokenistic; 19 20 ▸ Quality management was associated with clinical effectiveness of care, and to a lesser extent for patient safety culture; however, no link with patient-reported experience of care was established; 19 21 ▸ Greater variation of evidence-based organisation and patient safety strategies was found within, rather than between, countries; 22 ▸ An organisational management structure which supports innovation in care was associated with a more developed QMS; 23 ▸ Discussions of quality performance at executive board-level meetings were associated with higher levels of quality management; 24 and ▸ Accreditation and certification were associated with clinical leadership, systems for patient safety and clinical review, but not with clinical practice. 25 DUQuE produced an evidence-based guide on effective quality and safety strategies to assist purchasing agencies and hospital managers with decisions on implementation and improvement. 26 However, despite providing evidence of associations between hospital quality and a range of processes and outcomes, generalisability of DUQuE findings are limited to Europe. Extending this work to other healthcare systems will provide in-depth understanding of the relationships that exist within these systems, and will enable hospital benchmarking using standardised measures both within and between countries-an international first.
While DUQuE took a pathway analysis approach, it did not distinguish between QMS and clinical treatment processes delivered in emergency departments (EDs) and those of inpatient departments treating patients with stroke, AMI and hip fracture. Given that the ED is a common point of entry for all three conditions, inclusion of ED factors in the data for each condition is likely to bias the study towards ED performance. It is also likely that differences will exist between the quality of care delivered in the ED and other hospital departments providing care for stroke, AMI and hip fracture following admission, thereby biasing the findings for those departments. 27 Although there is work distinguishing the quality of care provided in the ED, and other inpatient department care, 28 the relationship between quality strategies used in the ED, and quality of care provided in the ED, has not been assessed. In addition, no distinction has been made between quality strategies and quality of care provided in the ED and quality strategies and quality of care provided in subsequent inpatient departments for any acute medical condition. Understanding the components of ED care in relation to specific care pathways can help identify which aspects of care are attributable to the ED versus other wards or departments. It is important to monitor the critical ED segment of care and distinguish this from care provided elsewhere, 28 so that barriers to the delivery of guidelineconcordant, evidence-based care can be identified and addressed using relevant, context-specific interventions. 29 The Deepening our Understanding of Quality in Australia (DUQuA) study involves substantial modification to the DUQuE study design, to advance the international evidence base. DUQuA aims to measure and examine relationships between organisation, department, and patient level factors within Australian hospitals. Specific research questions are: In line with DUQuE, we aim to further our understanding of the characteristics of Australian hospitals and hospital departments, and examine links to the quality of care provided to patients. 9 10 The DUQuA conceptual model (figure 1) outlines the expected relationships between organisation (hospital) and department-level constructs with patient-level factors (ie, clinical treatment processes, patient perceptions of care and nationally recorded outcomes) in three care pathways: stroke, AMI and hip fracture. Selection of these conditions is addressed below.
The specific objectives of DUQuA are to assess relationships between: (1) department-level QMS, leadership, culture and patient-level factors; (2) organisation-level QMS and patient-level factors; and (3) ED QMS, leadership, culture and patient-level factors.
Research design
The DUQuA project is a multilevel, cross-sectional study with data collection at organisation, department, professional and patient levels in hospitals across Australia. Organisation-level measures will consist of external assessment and self-reported QMS, and department-level measures will consist of external assessment of QMS and self-reported perceptions of leadership and culture. Patient-level measurements based on clinical treatment processes, patient perceptions of care and nationally recorded clinical outcomes are nested in hospital departments, which are in turn nested in hospitals in each of the six Australian states and two territories.
Sample size
Given our research design requires multilevel analysis, we used the following equation 30 to determine the design effect of the study and inflate the sample size accordingly: Taking this into account, an ICC of 0.16, higher than most ICCs in the literature, was used to calculate a conservative sample size. It reflects the median from the maternal health process measures, the most similar group of available reported ICCs. For this ICC, the minimum sample size required to answer our primary research question is 43 hospitals. However, in order to increase the power of the study, to be in line with simulation papers (which have shown that standard errors are estimated to be inadequate by 15% with <50 clusters), 36 and to allow for hospital refusal to participate or subsequent withdrawal, a decision to oversample at the organisation level was made.
Selection of clinical conditions
DUQuE originally tested relationships between QMS and four conditions (AMI, stroke, hip fracture and obstetrics). These conditions were selected because they cover a broad range of hospital care, there are evidence-based standards for clinical treatment processes against which compliance could be assessed, and there is demonstrated variability in both compliance with clinical treatment process measures and nationally reported outcomes of care, such as complications or mortality, allowing for analysis of associations between these measured constructs. 10 DUQuE conditions were retained except obstetrics; in Australia, maternity care is often provided in dedicated hospitals. Replacement conditions were considered but none were deemed suitable due to a lack of evidence-based standards for clinical treatment processes, or a lack of variability in compliance with processes or outcomes.
Selection and recruitment of hospitals Hospitals will be approached in all jurisdictions: the Australian Capital Territory (ACT), New South Wales (NSW), the Northern Territory (NT), Queensland (QLD), South Australia (SA), Tasmania (TAS), Victoria (VIC) and Western Australia (WA). To guarantee adequate data for collection, the inclusion criteria are (1) general public hospitals with approximately 200 beds or more, (2) with an ED, and (3) that regularly admit more than 30 each of stroke, AMI and hip fracture patients over a 3-month period. Preliminary work indicated that 70 hospitals meet these criteria and will be invited to participate. Table 1 lists the number of hospitals identified as eligible to participate by state.
The Director of Medical Services (DMS), or an equivalent senior hospital leader, will be the initial point of approach for recruiting hospitals. Following discussion with the DMS and other relevant hospital stakeholders, a letter will be sent to the hospital executive team of eligible hospitals inviting their participation. The DMS or equivalent will be recruited as a 'Local Principal Investigator' (LPI) at each hospital that accepts this invitation, acting as a hospital coordinator. For each hospital, one or more healthcare professionals will be recruited to support the LPI and coordinate data collection. The Royal Australasian College of Medical Administrators (RACMA) has agreed to support the DUQuA team during recruitment and data collection.
Other recruitment methods, including engaging a hospital executive network, or personal invitation, will be employed as necessary. LPIs and healthcare professionals will assist in operationalising the standardised recruitment strategy for staff and patients.
Selection and recruitment of participants
The source population for the study includes the Quality Manager at each participating hospital; all clinicians treating patients with stroke, AMI and hip fracture; and all patients with stroke, AMI and hip fracture meeting the study inclusion criteria. Where possible, we have adopted the same inclusion/exclusion criteria as DUQuE (The DUQuE Project team. Deepening our Understanding of Quality Improvement in Europe: Manual for Hospital Coordinators [unpublished material], 2011.). Specific details on selection of participants follows.
Quality Manager
Description This is the person responsible for the coordination of quality improvement activities in the hospital. He or she should have a good overview of all activities supporting quality improvement. This may be a formally appointed Quality Manager, or another professional in charge of managing aspects of quality in the hospital.
Recruitment
The Quality Manager will be invited by the DUQuA team to complete the Quality Management Systems Index (QMSI) questionnaire (see 'Organisation-level measures'). If more than one professional meets the description, then the most experienced person will be invited to participate until one questionnaire is completed.
Clinicians Description Clinicians will be invited to complete leadership and culture questionnaires. Clinician inclusion criteria are doctors, nurses and allied health professionals practising in the clinical area of the ED or a particular pathway (stroke, AMI, hip fracture) for at least 50% of their work time.
All clinicians that meet the inclusion criteria will be invited to participate in the leadership and culture questionnaire (see 'Department-level measures') until a minimum of 20 questionnaires for each department are completed at each hospital. The DUQuA team will invite clinicians to complete the questionnaire, by coordinating the dissemination of a web link to the online questionnaire.
Patients Description There are two patient-level measures that involve the collection of patient data. The inclusion criteria for each condition are listed in table 2. Patients who are admitted to the hospital with a primary diagnosis other than those listed in table 2 will be excluded.
Recruitment for patient perceptions of care measure All patients meeting the inclusion criteria who present to the hospital during the study period will be invited to complete the questionnaire. Additional criteria and screening will be applied to ensure that participation is voluntary and that participants are able to give informed consent. Healthcare professionals at each hospital will be trained to invite patients to complete the questionnaire. Recruitment will continue until a minimum of 30 questionnaires are completed for each condition at each hospital.
Clinical treatment processes indicator audit
The inclusion criteria (table 2) will be applied to records of patients admitted to the hospital between September 2014 and February 2015. Records of patients admitted to the hospital with a primary diagnosis other than those listed in table 2 will be excluded. For each condition in each hospital, 60 consecutive patient medical records will be extracted and reviewed until 30 audits of patients meeting the inclusion criteria have been completed. Healthcare professionals trained by the DUQuA team will undertake the medical record reviews.
Development, selection and collection of measures Measures developed and validated for DUQuE 9 10 15-17 22 37 were initially considered for DUQuA. During a 3-day consultation with the DUQuE lead researchers (RS and OG), we agreed on which constructs should be excluded from the DUQuA study based on a lack of relevance to the Australian healthcare system, poor variance demonstrated by a particular measure, an absence of a relationship with any other variables measured in DUQuE, or misalignment of the construct with our revised theoretical framework. Excluded constructs are: external pressure, hospital governance, hospital culture, hospital professional involvement, patient involvement in quality management and professionalism.
To establish new constructs not assessed as part of DUQuE (ie, department-level leadership and culture), literature reviews were performed to identify existing measures. Explicit criteria were used to assess and select measures, including psychometric properties, level of evidence and appropriateness for the Australian healthcare system. In particular, the significance of interhospital transfers in the care of patients with stroke, AMI and hip fracture was identified. Australian studies indicate that 14% of patients with hip fracture and a quarter of patients with AMI are transferred between hospitals, and 63% of Australian hospitals have ED protocols for interhospital transfers of patients with stroke. [38] [39] [40] Consequently, variables regarding the potential impact of interhospital transfer were incorporated to allow for their measurement.
Where the DUQuE measures or items were unsuitable for the Australian context, or where it was felt that newer evidence-based measures were available, we reviewed the literature for new measures, consulted with expert clinicians and refined specific items to ensure measures were appropriate and relevant. Stakeholder groups of healthcare professionals and researchers with expertise in clinical practice, quality or both were established to inform revisions to DUQuA measures and the introduction of new measures. New measures have been piloted in at least one hospital ( June 2015 and September 2015) to assess suitability and feasibility of use. The final list of DUQuA measures, content descriptions, evidence of reliability and validity, and data collection methods, is provided in table 3.
Organisation-level measures Development and selection
The three measures of organisation-level QMS are the QMSI, the Quality Management Compliance Index (QMCI) and the Clinical Quality Implementation Index (CQII). These measures, validated by DUQuE, have been modified by the DUQuA team in consultation with national quality assessment experts (eg, the Australian Council on Healthcare Standards) for the Australian context and to reflect changes made to the condition- 7 Open Access specific indicators. The adapted QMSI is a sevensubscale survey which provides a proxy measure for the managerial aspects of quality management that might influence the implementation of quality systems in hospitals. 15 The adapted QMCI is a four-subscale proxy measure for compliance with procedures used to plan, monitor and improve quality of care. 16 The adapted CQII is a seven-subscale proxy measuring implementation of QMS, including whether specialised quality management committees and hospital policies exist, and the level of compliance monitoring, system sustainability and improvement focus. 16 
Collection
The Quality Manager will complete the self-report paper QMSI questionnaire. The QMCI and CQII will be completed in a quality assessment site visit by experienced external hospital surveyors who will be trained by the DUQuA team. 
Department-level measures
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Collection Department-level QMS assessment will be completed in a quality assessment site visit by experienced external hospital assessors drawn from a pool of Australian Council on Healthcare Standards surveyors who will be trained by the DUQuA team.
Culture and leadership
Development and selection
The culture measure consists of two domain subscales from the Australian version 44 of the validated Safety Attitudes Questionnaire (SAQ) 41 'Teamwork climate' and 'Safety climate'. Two scales, each previously validated and measured on a four-point Likert scale, were combined to form the leadership measure: the 'Perceptions of management' domain subscale from the SAQ, 41 and the Leadership Effectiveness Scale. 42 These measures are combined in one questionnaire.
Collection
Clinicians will complete the self-report questionnaire online.
Patient-level measures Clinical treatment processes indicators Selection
The DUQuA team started with indicators for each condition used in the DUQuE study, 10 and refined these 45 Therefore, the indicators were amended to align with the NSF Clinical Audit and the national ACSQHC standards.
Development of AMI indicators
DUQuE AMI clinical indicators were compared against the 'Indicator Specification: Acute Coronary Syndromes Clinical Care Standard', developed by the ACSQHC and certified by the Federal Minister for Health. 46 Final indicators chosen for DUQuA align with the relevant indicators in this document.
Development of hip fracture indicators
DUQuE hip fracture clinical indicators were modified for DUQuA in consultation with the Co-Chair of the Australian and New Zealand Hip Fracture Registry (ANZHFR), and the guidelines produced by the ANZHFR. 47 Collection An audit of clinical treatment process indicators will be undertaken. For hospitals that submit data to the NSF Clinical Audit, data will be directly retrieved from the most recent audit (September 2014 to February 2015) within the NSF database.
i In hospitals not contributing to the NSF Clinical Audit, data will be collected via medical record review. As no national AMI or hip fracture registries were active during the NSF data collection period, AMI and hip fracture clinical treatment process data will also be collected via medical record review.
i The NSF provides training to internal clinicians for its biennial audit. The NSF reviews 40 consecutive medical records for each hospital. A random sample of 30 records will be selected for each participating DUQuA hospital.
Patient perceptions of care
Development and selection A modified version of the eight-scale, self-report UK-validated Patient Measure of Safety (PMOS) questionnaire, 43 50 which assesses patients' perceptions of the factors contributing to patient safety, will measure subjective patient factors. The instrument presents 43 items on a 5-point Likert scale from 1 (strongly disagree) to 5 (strongly agree).
The PMOS has been piloted in one hospital (ethically approved, HREC reference LNR/14/157) with stroke, AMI, and hip fracture patients. Stage 1 involved four patients who participated in a 'think aloud' study to provide an indication of the suitability of the content, length, and presentation of the measure. Stage 2 tested the refined measure with 31 patients to establish the suitability of the PMOS for use with a cohort of patients similar to patients likely to participate in DUQuA, and demonstrate the level of variability produced by the measure.
Collection
Patients will complete the self-report paper questionnaire. Patients may request assistance to complete the questionnaire from a family member or the trained clinician responsible for administering the questionnaire.
Nationally recorded clinical outcomes
Development and selection Clinical outcomes will be determined by analysing routine data collected by hospitals and submitted to the Australian Institute of Health and Welfare (AIHW), a national Australian Government data collection agency. Data will include the number of cases of each condition discharged by diagnosis, (including stratification by age and gender), in-hospital mortality, length of hospital stay, readmission, and mortality. Data will also be collected for the number of: percutaneous coronary interventions (AMI), thrombolysis procedures (stroke), and hip fracture operations performed in each hospital over the study period.
Collection
The DUQuA team will retrieve the required data from the AIHW.
Data analysis
The analysis plan for each research question is presented in table 4. Descriptive statistics will summarise the spread, frequencies or distributions of the variables of interest. Simple correlations, linear and logistic regression and multilevel modelling will be undertaken. The exact approach to the statistical analysis will depend on the distribution of the data, the variables that will need to be adjusted for (eg, case mix), and the final sample size achieved.
Multivariate modelling will take the form of a multilevel or hierarchical model in the first instance; with hospitals at the top level.
ii This type of regression will adjust for both hospital-level and department-level covariates. Subject to the results of this modelling, the levels may be adjusted to select individual patient impact measures as level 1 or, alternatively, a single-level model utilised. Employing multilevel methods will allow for the amount of variation in patient-level factors attributed to the hospital and department level, as well as which factors contribute to this variation, to be identified.
Ethics and dissemination
Regionally based Human Research Ethics Committees (HRECs) in Australia have approved the DUQuA project ii Sample size was calculated based on a two level hierarchical model, with hospital as the higher level. This model structure was selected as it will likely be the model requiring the largest sample, and which answers the primary research questions. Additional models that are tested will give more precise estimates as their sample size requirements will likely be less.
for NSW (14/206) iii , VIC (15/36) iii , ACT (15/131) iii , SA (15/260) iii , WA (15/118) iii and QLD (15/361) iii . Remaining regionally based ethical applications are under review, and governance requests for participating hospitals will be submitted following confirmation of the final sample.
Results of the DUQuA project will be disseminated to participating hospitals in the form of confidential national and international benchmarking reports with a set of data-driven recommendations. An extensive publication plan will support the dissemination of results including reporting on the international validation of measurement tools, associations between measures using linear and multilevel models, the extent to which hospital benchmarking can identify consistent high and low performers, and the impact of the ED and patient transfers on the delivery of care for the three selected conditions. This ground-breaking study, with international implications, has the potential to build a coalition of hospitals for subsequent interventional work, influence policymaker decisions on the implementation of quality and safety systems and processes, and ultimately improve the delivery of patient care in Australian hospitals. 
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